Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Roche Holding AG?

Accepted Answer

Según el último estado financiero (Form-10K), Roche Holding AG tiene un total de activos de $101,801, una ganancia neta profit de $8,277

Question 2

¿Cuáles son los ratios financieros clave para RHHVF?

Accepted Answer

El ratio corriente de Roche Holding AG es 1.45, el margen neto es 13.68, las ventas por acción son $75.43.

Question 3

¿Cómo se desglosan los ingresos de Roche Holding AG por segmento o geografía?

Accepted Answer

Roche Holding AG largest revenue segment is Roche Pharmaceuticals, at a revenue of 43,297,000,000 in the most earnings release.For geography, Switzerland is the primary market for Roche Holding AG, at a revenue of 747,000,000.

Question 4

¿Es rentable Roche Holding AG?

Accepted Answer

yes, según los últimos estados financieros, Roche Holding AG tiene una ganancia neta profit de $8,277

Question 5

¿Tiene Roche Holding AG alguna deuda?

Accepted Answer

yes, Roche Holding AG tiene una deuda de 70,034

Question 6

¿Cuántas acciones en circulación tiene Roche Holding AG?

Accepted Answer

Roche Holding AG tiene un total de acciones en circulación de 795.4

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	61,591	60,495	58,716	63,281	62,801	58,323
Revenue Growth (YoY)	5%	3%	-7%	1%	8%	-5%
Cost of Revenue	16,060	15,783	15,626	18,630	19,348	15,900
Gross Profit	45,531	44,712	43,090	44,651	43,453	42,423
Selling, General & Admin	13,890	13,758	13,518	12,130	12,100	12,075
Research & Development	--	13,042	13,237	14,053	13,707	12,151
Operating Expenses	24,720	24,625	24,561	24,734	24,922	23,454
Other Non Operating Income (Expenses)	-1,413	-172	-189	-109	-80	-115
Pretax Income	13,158	11,793	14,079	16,327	17,398	17,965
Income Tax Expense	2,836	2,606	1,721	2,796	2,463	2,897
Net Income	9,429	8,277	11,498	12,421	13,930	14,295
Net Income Growth	-11%	-28%	-7%	-11%	-3%	6%
Shares Outstanding (Diluted)	803	802	804	808	860	865
Shares Change (YoY)	0%	0%	-1%	-6%	-1%	0%
EPS (Diluted)	11.75	10.32	14.3	15.37	16.2	16.52
EPS Growth	-11%	-28%	-7%	-5%	-2%	6%
Free Cash Flow	13,202	15,085	11,446	13,251	16,427	11,876
Free Cash Flow Per Share	16.44	18.8	14.23	16.39	19.1	13.72
Gross Margin	73.92%	73.91%	73.38%	70.55%	69.19%	72.73%
Operating Margin	33.78%	33.2%	31.55%	31.47%	29.5%	32.52%
Profit Margin	15.3%	13.68%	19.58%	19.62%	22.18%	24.51%
Free Cash Flow Margin	21.43%	24.93%	19.49%	20.93%	26.15%	20.36%
EBITDA	23,544	23,510	21,993	23,761	22,974	23,527
EBITDA Margin	38.22%	38.86%	37.45%	37.54%	36.58%	40.33%
D&A For EBITDA	2,733	3,423	3,464	3,844	4,443	4,558
EBIT	20,811	20,087	18,529	19,917	18,531	18,969
EBIT Margin	33.78%	33.2%	31.55%	31.47%	29.5%	32.52%
Effective Tax Rate	21.55%	22.09%	12.22%	17.12%	14.15%	16.12%

Roche Holding AG (RHHVF) Price

RHHVF Stock Price Chart

RHHVF Income

Follow-Up Questions